Fireside Chat: Early Intervention vs. Monitoring in NPDR: Navigating the Controversy
Time: 4:00 pm
day: Day One
Details:
- Debate the merits of early treatment versus monitoring in non-proliferative diabetic retinopathy (NPDR), considering the potential to alter disease progression and prevent vision-threatening events
- Examine the significant industry investment in early intervention strategies, such as Genentech’s port delivery systems, and their potential to reduce the incidence of diabetic macular edema (DME) and other complications
- Analyze real-world data and expert opinions, noting that while historically most experts suggest a wait-and-see approach, the growing market and advancements in anti-VEGF therapies suggest a shift towards proactive treatment
